DMAC · DiaMedica Therapeutics Inc.

$6.75 +0.19 (+2.90%) At close · Sep 4

Russell 2000 member Rebalance outlook locked

Market Cap

$364.00M

53.93M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rick Pauls	President and Chief Executive Officer	$645,000	—	—	$1,652,400	$412,500	$17,450	$2,727,350
Julie Krop	M.D.^(d)^ Chief Medical Officer	$198,980	—	—	$1,421,100	$79,592	$7,891	$1,707,563
Scott Kellen	Chief Financial Officer and Secretary	$408,500	—	—	$619,650	$183,920	$17,450	$1,229,520

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rick Pauls	President and Chief Executive Officer	$593,250	—	—	$633,510	$306,975	$17,250	$1,550,985
Lorianne Masuoka	Chief Medical Officer	$403,277	—	—	$637,260	$116,667	$17,106	$1,174,310
Scott Kellen	Chief Financial Officer and Secretary	$374,250	—	—	$274,521	$147,934	$17,250	$813,955

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rick Pauls	President and Chief Executive Officer	$562,000	—	—	$396,553	$239,958	$16,650	$1,215,161
Scott Kellen	Chief Financial Officer and Secretary	$352,750	—	—	$146,790	$116,025	$16,650	$632,215
Kirsten Gruis	Former Chief Medical Officer	$298,643	—	—	$146,790	—	$150,650	$596,083
Julie Daves	SVP, Clinical Development Operations	$306,754	—	—	$118,309	$91,657	$16,650	$533,370

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rick Pauls	President and Chief Executive Officer	$522,796	—	—	$343,819	$198,342	$15,650	$1,080,607
Kirsten Gruis	Former Chief Medical Officer	$364,167	—	—	$487,789	$137,085	$15,650	$1,004,691
Scott Kellen	Chief Financial Officer and Secretary	$329,392	—	—	$116,549	$101,983	$15,650	$563,574

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rick Pauls	President and Chief Executive Officer	$477,448	—	—	$452,081	$191,590	$15,050	$1,136,169
Scott Kellen	Chief Financial Officer and Secretary	$286,211	—	—	$154,999	$90,460	$15,050	$546,720
Harry Alcorn	Jr., Pharm.D.^^ Senior Vice President of Clinical Operations	$302,112	—	—	$154,999	$73,107	$15,050	$545,268

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rick Pauls	President and Chief Executive Officer	$455,013	—	—	$190,624	$217,716	$14,850	$878,203
Harry Alcorn	Jr., Pharm.D.^^ Senior Vice President of Clinical Operations	$291,413	—	—	$119,140	$83,662	$14,850	$509,065
Scott Kellen	Chief Financial Officer and Secretary	$276,075	—	—	$119,140	$79,238	$14,850	$489,303

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Harry Alcorn	Jr., Pharm.D.^^ Chief Medical Officer	$273,750	—	—	$421,750	$68,400	$14,400	$778,300
Rick Pauls	President and Chief Executive Officer	$420,000	—	—	$890,736	$178,000	$14,650	$733,707
Scott Kellen	Chief Financial Officer and Secretary	$262,500	—	—	$336,557	$64,800	$13,950	$677,807

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rick Pauls	President and Chief Executive Officer	$315,208	—	—	$241,304	$163,875	$13,320	$733,707
Scott Kellen	Chief Financial Officer and Secretary	$200,833	—	—	$361,957	$70,200	$9,931	$642,921

Key facts CIK 1401040 CUSIP 25253X207 13F (30d) 58 filings 58 filers Visit website